A genetic mutation commonly found in cancer patients may also affect how the human body develops in the womb, according to ...

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

Scientists at CeMM and the Medical University of Vienna created CELLFIE, a tool to test thousands of genetic tweaks in CAR T ...

Vitamin D plays a vital role in the human body, far beyond just keeping bones strong. It helps your muscles move, allows your nerves to carry messages, supports your immune system, and helps control ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

Prof. Lukas Dow, biochemistry, and his team published a study in Nature on Aug. 16, detailing a new, more specific gene editing tool that they created to study cancer mutations through preclinical ...

The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even ...

Factor Bioscience Inc. (Factor), a Cambridge, Massachusetts-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer. (Nanowerk Spotlight) Immune-based cancer ...

The Emily Whitehead Foundation, established by the parents of the first child to receive life-saving CAR T-cell therapy, ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...